Financhill
Back

iRadimed 10K Form

Buy
60

IRMD
iRadimed

Last Price:
41.71
Seasonality Move:
12.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive IRMD News And Ratings

See the #1 stock for the next 7 days that we like better than IRMD

IRMD Financial Statistics

Sales & Book Value

Annual Sales: $65.56M
Cash Flow: $3.28M
Price / Cash Flow: 97.57
Annual Sales: $5.64
Price / Book: 7.42

Profitability

EPS (TTM): 1.36000
Net Income (TTM): $17.19M
Gross Margin: $50.16M
Return on Equity: 24.35%
Return on Assets: 20.37%

iRadimed Earnings Forecast

Key iRadimed Financial Ratios

  • The Gross Profit Margin over the past 12 years for IRMD is 76.50%.
  • The Selling, General & Administrative Expenses for IRMD have been equal to 41.59% of Gross Profit Margin.
  • The Research & Development expenses have been 4.36% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of IRMD is 26.22% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 8 years.

iRadimed Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: IRMD
CUSIP: 46266A
Website: iradimed.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.65
Quick Ratio: 3.8

Price-to-Earnings

Trailing P/E Ratio: 31.01
Forward P/E Ratio: 24.48

IRMD Technical Analysis vs Fundamental Analysis

Buy
60
iRadimed (IRMD) is a Buy

Is iRadimed a Buy or a Sell?

  • iRadimed stock is rated a Buy
    The current iRadimed [IRMD] share price is $41.86. The Score for IRMD is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.